- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
EirGenix (6589)
EirGenix stock price live, this page displays TW 6589 stock exchange data. View the 6589 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the EirGenix real time stock price chart below.
What Is the EirGenix Stock Price Today?
The EirGenix stock price today is 61.80.
What Is the Stock Symbol for EirGenix?
The stock symbol for EirGenix is ""6589.""
What Stock Exchange Does EirGenix Trade On?
EirGenix is listed and trades on the Taiwan stock exchange.
Is EirGenix a Good Stock to Buy?
Determining whether EirGenix—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 6589 quote. (ISIN: TW0006589005)
What Is the EirGenix Stock Price Today?
The EirGenix stock price today is 61.80.
What Is the Stock Symbol for EirGenix?
The stock symbol for EirGenix is ""6589.""
What Stock Exchange Does EirGenix Trade On?
EirGenix is listed and trades on the Taiwan stock exchange.
Is EirGenix a Good Stock to Buy?
Determining whether EirGenix—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 6589 quote. (ISIN: TW0006589005)
Taiwan
Currency in TWD
61.80
-0.70(-1.12%)
Closed·
Fair Value
An estimate of a EirGenix's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
61.20
62.60
52 wk Range
52.70
96.10
6589 Scorecard
Full Analysis
Management has been aggressively buying back shares
Earnings results expected today
1/2
Fair Value
An estimate of a EirGenix's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
61.2062.60
52 wk Range
52.7096.10
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
6589 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a EirGenix's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
138.00
Upside
+123.30%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Holds more cash than debt on its balance sheet
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
EirGenix Company Profile
EirGenix Inc. operates as a contract development and manufacturing company in Taiwan and internationally. The company offers cell line development, process development, analytical and quality control, cGMP manufacturing mammalian and microbial system, and antibody-drug conjugate services. It is also involved in the development of EG12014/EGI014, a Trastuzumab biosimilar, indicated for the treatment of cancer and currently under biologics license application status; EG1206A, a Pertuzumab biosimilar, indicated for the treatment of cancer and currently under Phase I stage; EG13074, indicated for the treatment of cancer and currently under Preclinical stage; TSY0110(EG12043), an antibody-drug conjugate, indicated for the treatment of cancer and currently under Preclinical stage; EG12021, Bevacizumab biosimilar, indicated for the treatment of cancer and currently under Preclinical stage; and EG62054, a biosimilar, currently under Preclinical stage. In addition, the company manufactures and sells covid-19 antigen rapid test; and EG74032, a CRM197 carrier protein. The company was incorporated in 2012 and is headquartered in New Taipei City, Taiwan.
Compare 6589 to Peers and Sector
Metrics to compare | 6589 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship6589PeersSector | |
|---|---|---|---|---|
P/E Ratio | −25.1x | −0.5x | −0.5x | |
PEG Ratio | −3.19 | 0.04 | 0.00 | |
Price/Book | 2.1x | 1.6x | 2.6x | |
Price / LTM Sales | 19.5x | 3.5x | 3.3x | |
Upside (Analyst Target) | 120.8% | 136.6% | 43.4% | |
Fair Value Upside | Unlock | 12.0% | 7.1% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 138.00
(+123.30% Upside)
Earnings
Latest Release
May 13, 2025
EPS / Forecast
-0.52 / -0.56
Revenue / Forecast
182.00M / 242.00M
FAQ
What Stock Exchange Does EirGenix Trade On?
EirGenix is listed and trades on the Taiwan Stock Exchange stock exchange.
What Is the Stock Symbol for EirGenix?
The stock symbol for EirGenix is "6589."
What Is the EirGenix Market Cap?
As of today, EirGenix market cap is 18.74B.
What Is EirGenix's Earnings Per Share (TTM)?
The EirGenix EPS (TTM) is -2.46.
When Is the Next EirGenix Earnings Date?
EirGenix will release its next earnings report on 07 Aug 2025.
From a Technical Analysis Perspective, Is 6589 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has EirGenix Stock Split?
EirGenix has split 4 times.
How Many Employees Does EirGenix Have?
EirGenix has 1000 employees.
What is the current trading status of EirGenix (6589)?
As of 08 Aug 2025, EirGenix (6589) is trading at a price of 61.80, with a previous close of 77.80. The stock has fluctuated within a day range of 61.20 to 62.60, while its 52-week range spans from 52.70 to 96.10.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.